Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina 29208, USA.
Int Rev Immunol. 2012 Feb;31(1):66-84. doi: 10.3109/08830185.2011.642909.
Inflammatory bowel disease (IBD) can be divided into two major categories, ulcerative colitis (UC) and Crohn disease (CD). While the main cause(s) of IBD remain unknown, a number of interventional and preventive strategies have been proposed for use against CD and UC. Many reports have focused on the use of alternative natural medicines as potential therapeutic interventions in IBD patients with minimal side effects. While the use of alternative medicines may be effective in IBD patients that are refractory to corticosteroids or thiopurins, alternative treatment strategies are limited and require extensive clinical testing before being optimized for use in patients.
炎症性肠病(IBD)可分为两大类,溃疡性结肠炎(UC)和克罗恩病(CD)。虽然 IBD 的主要病因仍不清楚,但已经提出了许多针对 CD 和 UC 的干预和预防策略。许多报告都集中在使用替代天然药物作为潜在的治疗干预措施,以治疗 IBD 患者,这些药物的副作用极小。虽然替代药物在对皮质类固醇或硫嘌呤类药物难治的 IBD 患者中可能有效,但替代治疗策略有限,需要进行广泛的临床测试,然后才能针对患者进行优化。